Praxis Precision Medicines, Inc. — Director's Dealing 2021

Jan 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Praxis Precision Medicines, Inc. (PRAX)
CIK: 0001689548
Period of Report: 2021-01-04

Reporting Person: Ravina Bernard (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-04	Common Stock	M	45000	$2.27	Acquired	56021	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Stock Option (Right to Buy)	$2.27	M	45000	Disposed	2028-10-18	Common Stock (45000.0)	Direct

Footnotes

F1: 25% of this option vested and became exercisable on August 21, 2019, with the remainder vesting in 36 equal monthly installments thereafter. This option was initially for 195,500 shares and the Reporting Person has exercised his option to purchase 56,021 shares since such grant date.